Invention Grant
- Patent Title: Use of tamoxifen for the treatment of cystic fibrosis in patients of both sexes
-
Application No.: US16089528Application Date: 2017-04-03
-
Publication No.: US11191738B2Publication Date: 2021-12-07
- Inventor: Giorgio Balduzzi
- Applicant: GB PHARMA S.R.L.
- Applicant Address: IT Pavia
- Assignee: GB PHARMA S.R.L.
- Current Assignee: GB PHARMA S.R.L.
- Current Assignee Address: IT Pavia
- Agency: Lucas & Mercanti, LLP
- Priority: ITUA2016A002292 20160405
- International Application: PCT/EP2017/057895 WO 20170403
- International Announcement: WO2017/174529 WO 20171012
- Main IPC: A61K31/138
- IPC: A61K31/138 ; A61K9/20 ; A61K9/00
Abstract:
The use of tamoxifen or a pharmaceutically acceptable salt as non estrogen-dependent acting drug for the treatment of cystic fibrosis in patients of both sexes is disclosed. Tamoxifen is preferably administered by inhalation route.
Public/Granted literature
- US20200297667A1 USE OF TAMOXIFEN FOR THE TREATMENT OF CYSTIC FIBROSIS IN PATIENTS OF BOTH SEXES Public/Granted day:2020-09-24
Information query
IPC分类:
